Antibiotice To Become The 'Nucleus' Of A National Pharmaceutical Company

BMI's view that the full privatisation of pharmaceutical company Antibiotice Iasi is extremely unlikely in the short term[1] has been given further credence following Romanian Prime Minister Emil Boc's declaration that the drugmaker is of national strategic interest. He stated that the firm requires greater government support and recognition from national and international markets.

To read the full article, please sign in or take a free trial.